Quick Facts at a Glance
- Recall Date
- March 17, 2026
- Hazard Level
- HIGH
- Brands
- XANAX, Viatris Specialty LLC
- Category
- Health & Personal Care
- Sold At
- Unknown
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL, PREGNANT, PREGNANT
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- XANAX, Viatris Specialty LLC
- Product type
- Alprazolam XR Tablets
- Model numbers
- Lot# 8177156, Exp Date: 02/28/2027
- UPC codes
- 58151-503, 58151-504, 58151-505, 58151-506, 58151-503-91, 58151-504-91, 58151-505-91, 58151-506-91
- Sizes
- 3 mg
- Sold at
- Unknown
- Where affected
- ALL
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
March 17, 2026
Reported by FDA DRUG
April 15, 2026
RecallRadar source check
April 22, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Failed Dissolution Specifications
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Viatris, Inc. or your healthcare provider for guidance. Notification method: Letter
About This Product
Xanax XR is an extended-release form of alprazolam used to treat anxiety disorders. It is prescribed by clinicians and distributed nationwide.
Why This Is Dangerous
Failed dissolution specifications may lead to insufficient drug release or dose inaccuracies, potentially reducing effectiveness.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
Patients may experience reduced anxiety control or withdrawal symptoms if treatment is interrupted.
Practical Guidance
How to identify if yours is affected
- Check the bottle for NDC 58151-506-91
- Inspect Lot# 8177156 and Exp 02/28/2027
- Verify 3 mg strength and 60-tablet count
Where to find product info
Look on the bottle label and packaging; FDA recall page for D-0444-2026
What timeline to expect
Recall processing and replacement/refund timelines vary by distributor
If the manufacturer is unresponsive
- Contact your healthcare provider
- File a consumer complaint with FDA if needed
How to prevent similar issues
- Verify NDC before dispensing
- Coordinate with pharmacists for substitution if needed
- Follow FDA recall updates for replacement options
Documentation advice
Keep recall notices, pharmacy communications, and any replacement or refund documentation
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
Brand: Xanax XR, Alprazolam, extended-release tablets. Dose: 3 mg, 60 tablets per bottle. Route: Rx only. Distributor: Viatris Specialty LLC, Morgantown, WV 06506, USA. Country of manufacture: Ireland. NDC: 58151-506-91. Lot numbers: Lot# 8177156. Expiration: 02/28/2027. Sold nationwide in the US.
Reported Incidents
No specific injuries or incidents are described in the provided information. The FDA notice does not list patient injuries or adverse events.
Key Facts
- 3 mg Xanax XR tablets
- 60 tablets per bottle
- Distributed nationwide in the US
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.
